Patents
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
08/2012
08/29/2012CN102000330B Nucleic acid vaccine adjuvant and construction method thereof
08/29/2012CN101979549B Gene medicament taking voltage-gated proton channel Hv1 as targeted locus for treatment of breast cancer
08/29/2012CN101940786B Application of immunogenic protein gene PilA of haemophilus parasuis
08/29/2012CN101928345B Human source antibody and humanization remolding method thereof
08/29/2012CN101240271B Toll-like receptor adjustment oligonucleotide and use thereof
08/29/2012CN101163796B Cationic lipids and methods of use
08/29/2012CN101028519B Pharmaceutical composition for treating immune diseases
08/28/2012US8252765 Treatment of cancer by inhibition of IGFBPs and clusterin
08/28/2012US8252763 RNAi therapeutic for treatment of hepatitis C infection
08/28/2012US8252761 Method of increasing murine ES cell differentiation with PCL2
08/28/2012US8252756 Nucleic acid functionalized nanoparticles for therapeutic applications
08/28/2012US8252755 Sense strand, antisense strand having complementarity to both the sense strand and a target gene, forming a duplex, a conjugate, facilitating cellular delivery, and a linker molecule; facilitates delivery to a cell, tissue or organism
08/28/2012US8252537 5' portion of an intestinal lactase-phlorizine hydrolase (LPH) gene; point mutations; solid phase synthesis; immunoassay; vectors; primers; host cells; antibodies; kits; gene therapy
08/28/2012US8252277 Virulent oncolytic herpes simplex virus strains engineered to counter the innate host response
08/28/2012CA2479414C Inhibition of the .beta.3 subunit of l-type ca2+ channels
08/28/2012CA2454073C Mutations in ion channels
08/28/2012CA2450470C Method for rapid screening of bacterial transformants and novel simian adenovirus proteins
08/28/2012CA2445578C Biological pacemaker comprising dominant-negative kir2.1aaa
08/28/2012CA2387805C Nucleic acids encoding endotheliases, endotheliases and uses thereof
08/23/2012WO2012112832A1 Compositions and methods for altering tissue specificity and improving aav9-mediated gene transfer
08/23/2012WO2012112696A1 Therapeutic compositions and methods for antibody and fc-containing targeting molecule-based targeted delivery of bioactive molecules by bacterial minicells
08/23/2012WO2012112578A2 Improved aav8 vector with enhanced functional activity and methods of use thereof
08/23/2012WO2012109798A1 Hbv treatment
08/23/2012WO2012091496A3 siRNA FOR INHIBITION OF Hif1α EXPRESSION AND ANTICANCER COMPOSITION CONTAINING THE SAME
08/23/2012WO2012061443A3 Compositions of a peptide targeting system for treating cancer
08/23/2012WO2012012541A3 SUSTAINED RELEASE siRNA FOR OCULAR DRUG DELIVERY
08/23/2012WO2010030751A9 New modalities for treatment of drug-resistant tuberculosis and other diseases
08/23/2012US20120214867 Bacteriophage T4 Nanoparticles for Eukaryotic Delivery
08/23/2012US20120214866 Treatment with cytokines
08/23/2012US20120214742 Gaba release-regulating agent in cerebellum
08/23/2012US20120214737 Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by nrg-2
08/23/2012US20120213848 Treatment of Infection Using Single Chain Antibody Gene Therapy
08/23/2012US20120213815 Vaccines and immunotherapeutics using codon-optimized il-15 and methods for using the same
08/23/2012US20120213778 Method of detecting and treating tuberous sclerosis complex associated disorders
08/23/2012US20120213777 Vascular endothelial growth factor 2
08/23/2012US20120213752 Isolated stromal cells and methods of using the same
08/23/2012US20120213749 Cardiac muscle regeneration using mesenchymal stem cells
08/23/2012US20120213738 Cardiac Repair By Reprogramming of Cardiac Fibroblasts Into Cardiomyocytes
08/23/2012US20120213731 Methods and compositions for treating autoimmune diseases
08/23/2012CA2827645A1 Enhanced therapeutic usage of a purine nucleoside phosphorylase or nucleoside hydrolase prodrug related applications
08/23/2012CA2827443A1 Therapeutic compositions and methods for antibody and fc-containing targeting molecule-based targeted delivery of bioactive molecules by bacterial minicells
08/23/2012CA2827375A1 Improved aav8 vector with enhanced functional activity and methods of use thereof
08/23/2012CA2826316A1 Compositions and methods for altering tissue specificity and improving aav9-mediated gene transfer
08/22/2012EP2489737A1 Interfering RNA duplex having blunt-ends and 3'-modifications
08/22/2012EP2489733A2 Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders
08/22/2012EP2489366A1 Use of spink6 gene and protein encoded therein in the manufacture of anti-tumor medicaments
08/22/2012EP2489348A1 Pharmaceutical composition containing medicament-containing fine particles and method for producing same
08/22/2012EP2488641A2 Supercoiled minicircle dna for gene therapy applications
08/22/2012EP2488165A1 Nanoparticle of the core-shell type suitable for delivering therapeutic oligonucleotides to target tissues and the use thereof for the preparation of a medicament for treating duchenne muscular dystrophy
08/22/2012EP1651050B1 Acellular tissue matrices made from galactose alpha-1,3-galactose -deficient tissue
08/22/2012EP1649028B1 Adenoviral vector-based vaccines
08/22/2012EP1584623B1 A group of nucleic acid fragments for prevention of hiv infection or aids and the usage thereof
08/22/2012CN1909918B T cell immunoreaction inhibitor
08/22/2012CN102648004A Photosensitizing compositions
08/22/2012CN102643858A Efficiently-replicated human hepatitis B virus recombinant vector and application thereof
08/22/2012CN102643854A Eukaryon recombinant plasmid, preparation process and applications thereof
08/22/2012CN102643822A Heartworm nucleic acid vaccine and method for preparing same
08/22/2012CN102643819A ShRNA of Rab23 and ientiviral vector and applications thereof
08/22/2012CN102643818A Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases
08/22/2012CN102643814A Antisense oligonucleotide for human miR-431 and application thereof
08/22/2012CN102643813A Human miR-504 antisense oligonucleotide and application thereof
08/22/2012CN102643812A Human miR-1227 antisense oligonucleotide and application thereof
08/22/2012CN102643811A Human miR-1229 antisense oligonucleotide and application thereof
08/22/2012CN102643810A Human miR-299-5p antisense oligonucleotide and application thereof
08/22/2012CN102643809A Antisense oligodeoxyncleotide of human miR-1274b and application thereof
08/22/2012CN102643808A Antisense oligodeoxyncleotide of human miR-1539 and application thereof
08/22/2012CN102643807A Antisense oligodeoxyncleotide of human miR-484 and application thereof
08/22/2012CN102643806A Antisense oligodeoxyncleotide of human miR-1913 and application thereof
08/22/2012CN102643785A Method for targeted inhibition of infiltration and transfer of glioma cells and application of method
08/22/2012CN102643343A Human derived anti-rabies virus glycoprotein gene engineering antibody and preparation and application thereof
08/22/2012CN102641509A Application of Epstein barr (EB) virus miR-BART7 antisense oligonucleotide in preparing medicine capable of treating nasopharynx cancer
08/22/2012CN102641508A Application of target up-regulation PAR-4 gene small ribonucleic acid (RNA) in preparing bladder cancer resisting drugs
08/22/2012CN102641503A Inhibitors of angiopoietin-like 4 protein, combinations, and their use
08/22/2012CN102641499A Construction and application of recombinant Peste des petits ruminants virus (PPRV) live vector vaccine for foot and mouth disease virus (FMDV) VP1 gene
08/22/2012CN102051358B Mosaic tumor specific gene expression regulation kit and application thereof
08/22/2012CN101429236B Type II non-structural protein 2B of dengue virus, recombinant expression vector, preparation and uses thereof
08/22/2012CN101063142B Human papilloma virus 16 type DNA vaccine and gene adjuvant and its application
08/21/2012US8247544 Method for producing a cell and/or tissue and/or disease phase specific medicament
08/21/2012US8247388 Role of miRNA in T cell leukemia
08/21/2012US8247385 Treatment and prevention of neurodegenerative diseases using gene therapy
08/21/2012US8247384 Methods and compositions for wound healing
08/21/2012US8246948 Stimulation of cartilage formation using reduced pressure treatment
08/21/2012CA2529179C Recombinant adeno-associated virus vector for treatment of alzheimer disease
08/21/2012CA2478910C Methods and means for monitoring and modulating gene silencing
08/21/2012CA2450206C Improved yield of chordopoxvirus by propagation at low temperature
08/21/2012CA2362830C Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
08/16/2012WO2012109567A2 Treatment of angiogenesis disorders
08/16/2012WO2012109469A2 Methods of treating alzheimer's disease with apo a-1 milano
08/16/2012WO2012109363A2 Mucus penetrating gene carriers
08/16/2012WO2012109329A2 Methods for treatment of melanoma
08/16/2012WO2012109214A1 Targeted transduction of aav vectors
08/16/2012WO2012109199A1 Neural transfection reagents
08/16/2012WO2012108843A1 Treating cancer by inhibiting expression of olfm4, sp5, tobi, arjdia, fbni or hat1
08/16/2012WO2012108397A1 Novel lipid
08/16/2012WO2012107073A1 Ubiad1 for cellular coenzyme q10 synthesis and cardiovascular oxidative protection
08/16/2012WO2012075379A3 Liquid viral formulations
08/16/2012WO2012075376A3 Lyophilized viral formulations
08/16/2012WO2012071561A3 Anti-il-6 antibodies for the treatment of anemia
08/16/2012WO2012071554A3 Anti-il-6 antibodies for the treatment of oral mucositis
08/16/2012WO2012068456A3 Compositions and methods for treating obesity
1 ... 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 ... 870